Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Neurologic disorders complicating pregnancy

Men-Jean Lee, MD
Susan Hickenbottom, MD, MS
Section Editors
Michael J Aminoff, MD, DSc
Charles J Lockwood, MD, MHCM
Deputy Editors
Janet L Wilterdink, MD
John F Dashe, MD, PhD


Pregnancy adds a unique and, at times, challenging facet to the management of neurologic disease. The pregnant state can affect many neurologic diseases, while certain neurologic diseases or their treatments may have a significant negative effect on pregnancy, labor, or delivery. This topic review will focus on the relationship between pregnancy and a wide spectrum of neurologic illnesses.


Cerebrovascular disease during pregnancy results from any of three major mechanisms: arterial infarction/ischemia, hemorrhage, or venous thrombosis. Pregnancy and the postpartum period are associated with a marked increase in the relative risk and a small increase in the absolute risk of stroke.

Risk factors for stroke related to pregnancy include cesarean delivery, pregnancy-induced hypertension, postpartum infection, and possibly multiple gestations. In addition, conditions unique to pregnancy can occur, which can present as either a stroke or a stroke-like event. These include eclampsia, peripartum cardiomyopathy, peripartum angiopathy, and gestational trophoblastic disease. Of these, preeclampsia/eclampsia is the most common cause of stroke in pregnancy. Other causes are listed in Table 1 (table 1). The risk of stroke in women with preeclampsia/eclampsia is discussed in detail separately. (See "Management of hypertension in pregnant and postpartum women", section on 'Indications for antihypertensive therapy'.)

Cerebrovascular disease and stroke in pregnancy is discussed in detail separately. (See "Cerebrovascular disorders complicating pregnancy".)


Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system typically characterized by relapses and remissions of neurologic deficits. MS affects women more than men by a ratio of approximately 2:1; the mean age of onset of MS is approximately 30 years. (See "Pathogenesis and epidemiology of multiple sclerosis" and "Clinical features of multiple sclerosis in adults".)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Oct 11, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Finkelsztejn A, Brooks JB, Paschoal FM Jr, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011; 118:790.
  2. Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998; 339:285.
  3. Vukusic S, Hutchinson M, Hours M, et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004; 127:1353.
  4. Bove R, Alwan S, Friedman JM, et al. Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol 2014; 124:1157.
  5. Hughes SE, Spelman T, Gray OM, et al. Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult Scler 2014; 20:739.
  6. Worthington J, Jones R, Crawford M, Forti A. Pregnancy and multiple sclerosis--a 3-year prospective study. J Neurol 1994; 241:228.
  7. Sadovnick AD, Eisen K, Hashimoto SA, et al. Pregnancy and multiple sclerosis. A prospective study. Arch Neurol 1994; 51:1120.
  8. Houtchens MK. Pregnancy and multiple sclerosis. Semin Neurol 2007; 27:434.
  9. Langer-Gould A, Beaber BE. Effects of pregnancy and breastfeeding on the multiple sclerosis disease course. Clin Immunol 2013; 149:244.
  10. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118 ( Pt 1):253.
  11. Verdru P, Theys P, D'Hooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg 1994; 96:38.
  12. Ramagopalan S, Yee I, Byrnes J, et al. Term pregnancies and the clinical characteristics of multiple sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2012; 83:793.
  13. Ponsonby AL, Lucas RM, van der Mei IA, et al. Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology 2012; 78:867.
  14. Operskalski EA, Visscher BR, Malmgren RM, Detels R. A case-control study of multiple sclerosis. Neurology 1989; 39:825.
  15. Hernán MA, Hohol MJ, Olek MJ, et al. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000; 55:848.
  16. Alonso A, Jick SS, Olek MJ, et al. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 2005; 62:1362.
  17. Thorogood M, Hannaford PC. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 1998; 105:1296.
  18. Hellwig K, Correale J. Artificial reproductive techniques in multiple sclerosis. Clin Immunol 2013; 149:219.
  19. Correale J, Farez MF, Ysrraelit MC. Increase in multiple sclerosis activity after assisted reproduction technology. Ann Neurol 2012; 72:682.
  20. Voskuhl RR. Assisted reproduction technology in multiple sclerosis: giving birth to a new avenue of research in hormones and autoimmunity. Ann Neurol 2012; 72:631.
  21. Laplaud DA, Leray E, Barrière P, et al. Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology 2006; 66:1280.
  22. Hellwig K, Beste C, Brune N, et al. Increased MS relapse rate during assisted reproduction technique. J Neurol 2008; 255:592.
  23. Hellwig K, Schimrigk S, Beste C, et al. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol 2009; 61:65.
  24. Michel L, Foucher Y, Vukusic S, et al. Increased risk of multiple sclerosis relapse after in vitro fertilisation. J Neurol Neurosurg Psychiatry 2012; 83:796.
  25. Franklin GM, Tremlett H. Multiple sclerosis and pregnancy: what should we be telling our patients? Neurology 2009; 73:1820.
  26. Kelly VM, Nelson LM, Chakravarty EF. Obstetric outcomes in women with multiple sclerosis and epilepsy. Neurology 2009; 73:1831.
  27. Dahl J, Myhr KM, Daltveit AK, et al. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 2005; 65:1961.
  28. Mueller BA, Zhang J, Critchlow CW. Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol 2002; 186:446.
  29. Chen YH, Lin HL, Lin HC. Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study. Mult Scler 2009; 15:606.
  30. Ferrero S, Pretta S, Ragni N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004; 115:3.
  31. Coyle PK. Multiple sclerosis and pregnancy prescriptions. Expert Opin Drug Saf 2014; 13:1565.
  32. Ghezzi A, Annovazzi P, Portaccio E, et al. Current recommendations for multiple sclerosis treatment in pregnancy and puerperium. Expert Rev Clin Immunol 2013; 9:683.
  33. Coyle PK. Multiple sclerosis in pregnancy. Continuum (Minneap Minn) 2014; 20:42.
  34. Lu E, Wang BW, Guimond C, et al. Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review. Neurology 2012; 79:1130.
  35. Coyle PK, Sinclair SM, Scheuerle AE, et al. Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events. BMJ Open 2014; 4:e004536.
  36. Fragoso YD, Boggild M, Macias-Islas MA, et al. The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis. Clin Neurol Neurosurg 2013; 115:154.
  37. Achiron A, Rotstein Z, Noy S, et al. Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study. J Neurol 1996; 243:25.
  38. Weinreb HJ. Demyelinating and neoplastic diseases in pregnancy. Neurol Clin 1994; 12:509.
  39. de Seze J, Chapelotte M, Delalande S, et al. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler 2004; 10:596.
  40. Achiron A, Kishner I, Dolev M, et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 2004; 251:1133.
  41. Kieseier BC, Wiendl H. Postpartum disease activity and breastfeeding in multiple sclerosis revisited. Neurology 2010; 75:392.
  42. Portaccio E, Ghezzi A, Hakiki B, et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology 2011; 77:145.
  43. Langer-Gould A, Huang SM, Gupta R, et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 2009; 66:958.
  44. Hellwig K, Rockhoff M, Herbstritt S, et al. Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses. JAMA Neurol 2015; 72:1132.
  45. Airas L, Jalkanen A, Alanen A, et al. Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurology 2010; 75:474.
  46. Hale TW, Siddiqui AA, Baker TE. Transfer of interferon β-1a into human breastmilk. Breastfeed Med 2012; 7:123.
  47. Mabie WC. Peripheral neuropathies during pregnancy. Clin Obstet Gynecol 2005; 48:57.
  48. Meems M, Truijens S, Spek V, et al. Prevalence, course and determinants of carpal tunnel syndrome symptoms during pregnancy: a prospective study. BJOG 2015; 122:1112.
  49. Stevens JC, Beard CM, O'Fallon WM, Kurland LT. Conditions associated with carpal tunnel syndrome. Mayo Clin Proc 1992; 67:541.
  50. Padua L, Aprile I, Caliandro P, et al. Symptoms and neurophysiological picture of carpal tunnel syndrome in pregnancy. Clin Neurophysiol 2001; 112:1946.
  51. McLennan HG, Oats JN, Walstab JE. Survey of hand symptoms in pregnancy. Med J Aust 1987; 147:542.
  52. Wand JS. Carpal tunnel syndrome in pregnancy and lactation. J Hand Surg Br 1990; 15:93.
  53. Padua L, Aprile I, Caliandro P, et al. Carpal tunnel syndrome in pregnancy: multiperspective follow-up of untreated cases. Neurology 2002; 59:1643.
  54. Mondelli M, Rossi S, Monti E, et al. Prospective study of positive factors for improvement of carpal tunnel syndrome in pregnant women. Muscle Nerve 2007; 36:778.
  55. Hilsinger RL Jr, Adour KK, Doty HE. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol 1975; 84:433.
  56. Berić A. Peripheral nerve disorders in pregnancy. Adv Neurol 1994; 64:179.
  57. Vrabec JT, Isaacson B, Van Hook JW. Bell's palsy and pregnancy. Otolaryngol Head Neck Surg 2007; 137:858.
  58. Sax TW, Rosenbaum RB. Neuromuscular disorders in pregnancy. Muscle Nerve 2006; 34:559.
  59. Shmorgun D, Chan WS, Ray JG. Association between Bell's palsy in pregnancy and pre-eclampsia. QJM 2002; 95:359.
  60. Gillman GS, Schaitkin BM, May M, Klein SR. Bell's palsy in pregnancy: a study of recovery outcomes. Otolaryngol Head Neck Surg 2002; 126:26.
  61. Cohen Y, Lavie O, Granovsky-Grisaru S, et al. Bell palsy complicating pregnancy: a review. Obstet Gynecol Surv 2000; 55:184.
  62. Chan LY, Tsui MH, Leung TN. Guillain-Barré syndrome in pregnancy. Acta Obstet Gynecol Scand 2004; 83:319.
  63. Luijckx GJ, Vles J, de Baets M, et al. Guillain-Barré syndrome in mother and newborn child. Lancet 1997; 349:27.
  64. Hoff JM, Gilhus NE, Daltveit AK. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. Neurology 2005; 64:459.
  65. Gunaydin B, Bozkurt N, Emmez G, et al. Combined spinal epidural anaesthesia for elective caesarean section in a parturient with Friedreich’s ataxia. Anesteziol i Ratownictwo 2012; 6:409.
  66. Wong CA, Scavone BM, Dugan S, et al. Incidence of postpartum lumbosacral spine and lower extremity nerve injuries. Obstet Gynecol 2003; 101:279.
  67. Gilchrist JM. Muscle disease. Adv Neurol 2002; 90:241.
  68. Ciafaloni E, Pressman EK, Loi AM, et al. Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy. Neurology 2006; 67:1887.
  69. Rudnik-Schöneborn S, Glauner B, Röhrig D, Zerres K. Obstetric aspects in women with facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and congenital myopathies. Arch Neurol 1997; 54:888.
  70. Cervera R, Asherson RA, Font J, et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 1997; 76:203.
  71. Cardoso F. Chorea gravidarum. Arch Neurol 2002; 59:868.
  72. DeAngelis LM. Central nervous system neoplasms in pregnancy. Adv Neurol 1994; 64:139.
  73. Simon RH. Brain tumors in pregnancy. Semin Neurol 1988; 8:214.
  74. Michelsen JJ, New PF. Brain tumour and pregnancy. J Neurol Neurosurg Psychiatry 1969; 32:305.
  75. Carroll RS, Zhang J, Black PM. Expression of estrogen receptors alpha and beta in human meningiomas. J Neurooncol 1999; 42:109.
  76. Pallud J, Mandonnet E, Deroulers C, et al. Pregnancy increases the growth rates of World Health Organization grade II gliomas. Ann Neurol 2010; 67:398.
  77. Pallud J, Duffau H, Razak RA, et al. Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group. J Neurol 2009; 256:2014.
  78. Ng J, Kitchen N. Neurosurgery and pregnancy. J Neurol Neurosurg Psychiatry 2008; 79:745.
  79. Stevenson CB, Thompson RC. The clinical management of intracranial neoplasms in pregnancy. Clin Obstet Gynecol 2005; 48:24.
  80. MARX GF, ZEMAITIS MT, ORKIN LR. Cerebrospinal fluid pressures during labor and obstetrical anesthesia. Anesthesiology 1961; 22:348.
  81. Finfer SR. Management of labour and delivery in patients with intracranial neoplasms. Br J Anaesth 1991; 67:784.
  82. American College of Obstetricians and Gynecologists' Committee on Obstetric Practice. Committee Opinion No. 656: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol 2016; 127:e75.
  83. Yu JN. Pregnancy and extracranial shunts: case report and review of the literature. J Fam Pract 1994; 38:622.
  84. Maheut-Lourmière J, Chu Tan Si. [Hydrocephalus during pregnancy with or without neurosurgical history in childhood. Practical advice for management]. Neurochirurgie 2000; 46:117.
  85. Landwehr JB Jr, Isada NB, Pryde PG, et al. Maternal neurosurgical shunts and pregnancy outcome. Obstet Gynecol 1994; 83:134.
  86. Littleford JA, Brockhurst NJ, Bernstein EP, Georgoussis SE. Obstetrical anesthesia for a parturient with a ventriculoperitoneal shunt and third ventriculostomy. Can J Anaesth 1999; 46:1057.
  87. Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976) 2001; 26:S2.
  88. American College of Obstetricians and Gynecologists. ACOG Committee Opinion: Number 275, September 2002. Obstetric management of patients with spinal cord injuries. Obstet Gynecol 2002; 100:625.
  89. Pereira L. Obstetric management of the patient with spinal cord injury. Obstet Gynecol Surv 2003; 58:678.
  90. Westgren N, Hultling C, Levi R, Westgren M. Pregnancy and delivery in women with a traumatic spinal cord injury in Sweden, 1980-1991. Obstet Gynecol 1993; 81:926.
  91. Maehama T, Izena H, Kanazawa K. Management of autonomic hyperreflexia with magnesium sulfate during labor in a woman with spinal cord injury. Am J Obstet Gynecol 2000; 183:492.